Related Experiment Video
Updated: Aug 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome
María Gracia Caletti1, Horacio Lejarraga, Diana Kelmansky
1Nephrology Service, Garrahan Hospital, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina.
Insights
Children with hemolytic-uremic syndrome (HUS) treated with early protein restriction and ACE inhibitors showed better long-term kidney function compared to older treatment methods. This highlights improved management strategies for HUS complications.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Internal Medicine
Background:
- Renal disease is a significant long-term complication of hemolytic-uremic syndrome (HUS).
- Understanding long-term renal function outcomes in HUS patients is crucial for effective management.
- Comparative studies are needed to evaluate evolving treatment strategies for HUS-related renal complications.
Purpose of the Study:
- To compare the long-term renal function outcomes in children with HUS treated with different therapeutic approaches.
- To assess the impact of early protein restriction and angiotensin-converting enzyme inhibitors (ACEi) on renal function.
- To identify factors contributing to better renal outcomes in pediatric HUS patients.
Main Methods:
- A comparative study analyzed renal function in two groups of children with HUS.
- Group 1 (19 children, 1960-1980) received a low-sodium diet, antihypertensives, and late protein restriction.
- Group 2 (26 children, 1988-2002) received a low-sodium diet, early protein restriction, and ACE inhibitors.
- Long-term renal function was evaluated using the inverse of plasma creatinine (1/[Cr]) over time, analyzed with linear regression.
Main Results:
- Children in Group 1 showed a significantly higher incidence of declining renal function (negative slopes in 1/[Cr] over time).
- Children in Group 2 exhibited a higher proportion of stable or improving renal function (positive slopes in 1/[Cr]).
- Fisher's exact test confirmed significantly more children with declining renal function in Group 1 compared to Group 2.
Conclusions:
- Contemporary treatment strategies, including early protein restriction and ACE inhibitors, are associated with better long-term renal function in children with HUS.
- These findings suggest that modern therapeutic interventions can mitigate the progression of renal disease following HUS.
- Early implementation of dietary and pharmacological interventions is key to improving renal outcomes in pediatric HUS.
Abstract:
Renal disease is the most important long-term complication of hemolytic-uremic syndrome (HUS). A comparative study of renal function was carried out in two groups of patients. Group 1 included 19 children followed for a median of 11 years, 1960-1980, with a low-sodium diet, antihypertensive drugs, and a restricted protein intake in the end stage of renal disease. Group 2 included 26 children treated for a median of 9 years, 1988-2002, on a low-sodium diet, early restriction of protein intake according to recommendations, and angiotensin converting enzyme inhibitors (ACEi). Long-term renal function was assessed by the inverse of the plasma creatinine concentration (1/[Cr]) over time. Linear regression lines were fitted to individual values of 1/[Cr] for each child. Regression coefficients of children in group 1 were all negative, ranging from -0.031 to -0.00043; 7 were significantly different from zero, indicating a linear fall in renal function over time. In contrast, children from group 2 had 11 negative slopes (only 1 significant) and 15 positive slopes, ranging from 0.17893 to -0.3899. Fisher's exact test showed that group 1 had significantly more children with negative slopes than group 2. This comparatively better long-term outcome of renal function in children under contemporary treatment was probably associated with early restriction of protein and use of ACEi.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
